HEAT-TREATED TANTALUM-ALLOY PRODUCTS, IMPLANTABLE MEDICAL DEVICES INCORPORATING SAME, AND METHODS OF PROCESSING TANTALUM-ALLOY PRODUCTS
    3.
    发明申请
    HEAT-TREATED TANTALUM-ALLOY PRODUCTS, IMPLANTABLE MEDICAL DEVICES INCORPORATING SAME, AND METHODS OF PROCESSING TANTALUM-ALLOY PRODUCTS 审中-公开
    热处理的钛合金产品,含有其的可植入医疗装置以及处理钛合金产品的方法

    公开(公告)号:WO2013055489A1

    公开(公告)日:2013-04-18

    申请号:PCT/US2012/055232

    申请日:2012-09-13

    CPC classification number: A61L31/022 A61L31/14

    Abstract: The present disclosure is directed to tantalum-alloy products, implantable medical devices that incorporate tantalum-alloy products such as stents or other implantable medical devices, methods of making and/or processing the tantalum-alloy products and implantable medical devices, and methods of using the implantable medical devices. In an embodiment, a stent includes a stent body having a plurality of struts. At least a portion of the stent body is made from a tantalum alloy. The tantalum alloy includes a tantalum content of about 77 weight % ("wt %") to about 92 wt %, a niobium content of about 7 wt % to about 13 wt %, and a tungsten content of about 1 wt % to about 10 wt %. The tantalum alloy exhibits at least one mechanical property modified by heat treatment thereof, such as yield strength, ultimate tensile strength, or ductility.

    Abstract translation: 本公开涉及钽合金产品,结合钽合金产品例如支架或其他可植入医疗装置的可植入医疗装置,制造和/或加工钽合金产品和可植入医疗装置的方法以及使用方法 可植入医疗器械。 在一个实施例中,支架包括具有多个支柱的支架主体。 支架主体的至少一部分由钽合金制成。 钽合金包括约77重量%(“重量%”)至约92重量%的钽含量,约7重量%至约13重量%的铌含量和约1重量%至约10重量%的钨含量 重量%。 钽合金表现出至少一种通过其热处理改性的机械性能,例如屈服强度,极限拉伸强度或延展性。

    IMPROVED MEDICAL DEVICE OF TERNARY ALLOY OF MOLYBDENUM AND RHENIUM
    4.
    发明申请
    IMPROVED MEDICAL DEVICE OF TERNARY ALLOY OF MOLYBDENUM AND RHENIUM 审中-公开
    改进的钼和铑三次合金医疗装置

    公开(公告)号:WO2010141897A2

    公开(公告)日:2010-12-09

    申请号:PCT/US2010/037511

    申请日:2010-06-04

    CPC classification number: A61L31/022 C22C27/00

    Abstract: A medical device such as, for example, an implantable expandable stent is constructed of a ternary alloy of molybdenum, rhenium, and a third metal. In a preferred embodiment, the third metal is a refractory metal selected to improve the ductility of the alloy. The alloy may further be advantageously constructed to have a crystal structure selected from HCP, BCC, FCC, and tetragonal to further optimize the physical characteristics of the medical device.

    Abstract translation: 诸如例如可植入式可扩张支架的医疗装置由钼,铼和第三金属的三元合金构成。 在优选实施例中,第三金属是选择用于改善合金的延展性的难熔金属。 还可以有利地将合金构造成具有选自HCP,BCC,FCC和四方晶的晶体结构,以进一步优化医疗器件的物理特性。

    RADIOPAQUE INTRALUMINAL STENTS COMPRISING COBALT-BASED ALLOYS CONTAINING ONE OR MORE PLATINUM GROUP METALS, REFRACTORY METALS, OR COMBINATIONS THEREOF
    7.
    发明申请
    RADIOPAQUE INTRALUMINAL STENTS COMPRISING COBALT-BASED ALLOYS CONTAINING ONE OR MORE PLATINUM GROUP METALS, REFRACTORY METALS, OR COMBINATIONS THEREOF 审中-公开
    包含含有一种或多种铂族金属,碱金属或其组合的基于钴的合金的放射性体系

    公开(公告)号:WO2012068358A1

    公开(公告)日:2012-05-24

    申请号:PCT/US2011/061161

    申请日:2011-11-17

    CPC classification number: A61L31/022 A61L31/18

    Abstract: Embodiments are directed to radiopaque implantable structures ( e.g ., stents) formed of cobalt-based alloys that comprise cobalt, chromium and one or more platinum group metals, refractory metals, or combinations thereof. Platinum group metals include platinum, palladium, ruthenium, rhodium, osmium, and iridium. Here, the term "refractory metals" include zirconium, niobium, rhodium, molybdenum, halfnium, tantalum, tungsten, rhenium, as well as the precious metals silver and gold. In one embodiment, the one or more included platinum group or refractory metals substitute for nickel, such that the alloy is substantially nickel free. The stents exhibit improved radiopacity as compared to similar alloys including greater amounts of nickel.

    Abstract translation: 实施例涉及由包含钴,铬和一种或多种铂族金属,难熔金属或其组合的钴基合金形成的不透射线的可植入结构(例如,支架)。 铂族金属包括铂,钯,钌,铑,锇和铱。 这里,术语“难熔金属”包括锆,铌,铑,钼,铌,钽,钨,铼以及贵金属银和金。 在一个实施方案中,一种或多种包括的铂族或难熔金属代替镍,使得该合金基本上不含镍。 与包括更大量的镍的类似合金相比,支架表现出改善的射线不透性。

Patent Agency Ranking